Investors bet big on AI for health diagnostics

We’re seeing a new wave of venture investments in healthtech companies — especially those with strong artifical intelligence and machine learning components. Led by some of the world’s largest biopharma companies and tech-focused venture capitalists, these investments are backing efforts to speed drug discovery, improve tests and treatments, and further medical research. For now, most of the investment is focused in the diagnostics/tools (Dx/Tools) sector.

Read the full story here

Leave a Reply

Your email address will not be published.